Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
1% pilocarpine mouthwash for xerostomia in head and neck radiotherapy patients
IRCT20210830052335N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in xerostomia comparing 1% pilocarpine mouthwash with Placebo mouthwash (2 arms). Primary endpoint: Change in salivation. Started Sep 2021; status: completed.
02
Drugs
pilocarpine
03
Conditions
xerostomia
Beyond the preview
Go deeper on IRCT20210830052335N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210830052335N1.